A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer
NCT06527300 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2025-01-24
Summary
This is a multicenter, open-label, single-arm, phase II study to evaluate the efficacy, safety, and pharmacokinetics of NHWD-870 HCl in adults and adolescents with advanced NUT cancer.
Conditions
- Advanced Solid Tumor (Phase 1)
Interventions
- DRUG
-
NHWD-870 HCl
Administered P.O.
Sponsors & Collaborators
-
Zhejiang Wenda Medical Technology Co., Ltd.
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 12 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-25
- Primary Completion
- 2025-06-30
- Completion
- 2025-12-30
Countries
- China
Study Locations
More Related Trials
-
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
NCT06169579 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors
NCT06773091 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors
NCT05036291 ·Status: TERMINATED ·Phase: PHASE1
-
Cadonilimab (AK104) in the Treatment of Nasopharyngeal Carcinoma
NCT05790200 ·Status: UNKNOWN ·Phase: PHASE2
-
A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
NCT06300216 ·Status: NOT_YET_RECRUITING
-
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
NCT06239727 ·Status: RECRUITING ·Phase: PHASE3
-
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
NCT06799637 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors
NCT06076291 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma
NCT04769076 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
CAN1012 Combined With PD-1 in Patients With Solid Tumors
NCT06410703 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC
NCT04015661 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
NCT06241599 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor
NCT07327294 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
6MW3511 in Patients With Advanced Solid Tumor
NCT05524194 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
NCT03792750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer
NCT06196736 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid Tumors
NCT06172309 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm
NCT05048160 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors
NCT06592417 ·Status: RECRUITING ·Phase: PHASE1
-
Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours
NCT02314884 ·Status: UNKNOWN ·Phase: PHASE1
-
Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT06669611 ·Status: RECRUITING ·Phase: PHASE3
-
Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
NCT03015727 ·Status: UNKNOWN ·Phase: PHASE3
-
Checkpoint Inhibitors in Patients With Solid Tumors: a Retrospective Real-world Study
NCT05719324 ·Status: UNKNOWN
-
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
NCT05877924 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC
NCT06472713 ·Status: RECRUITING ·Phase: PHASE2